Implanet
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Technopole Bordeaux Montesquieu Allee Fr...Phone Number
+33 557995555Website
www.implanet.comRevenue
$7.8 MillionStock Symbol
ALIMPIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Implanet
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its activity revolves around two product ranges, a comprehensive innovative solution for improving the treatment of spinal pathologies (JAZZ® and OSD), as well as the MADISON implant for first-line prosthetic knee surgery. Implanet's tried-and-tested orthopedic platform is based on the traceability of its products. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States, the CE mark in Europe and ANVISA approval in Brazil. IMPLANET employs 29 staff and recorded sales of 6.0 million in 2020.Explore more
Implanet Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Implanet your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Implanet is spiking on competitors!
Website visits: Recent activity has been detected on your website
Implanet, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Implanet had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Implanet
Funding: Get notified immidiatlly once Implanet has new funding data
Check if Implanet has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Implanet launches new products
Earning: See what the market has to say on Implanet recently announced quarterly report
Recommended Actions
Find VP level buyers at Implanet
Find 3 more new buyers
Company Profile Activity
Activity Insights
Implanet is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Implanet is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Implanet.
Implanet financials insights
Gather financial insights about Implanet, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Debt
$2.1M
Implanet Tech Stack
A closer look at the technologies used by Implanet
See more technologies
Most Recent Scoops
Funding
Funding
New Hire
Executive Move
Earnings
Sales
Earnings
Sales
Earnings
Sales
Implanet News & Media
Implanet to Co-Exhibit Alongside 8i Robotics’ Next-Gen Robotic Solutions at NASS1 booth #2412 in Chicago
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, will share booth #2412 alongside fellow innovator 8i Robotics, pioneering the development of a multi-arm robot system for use in spine and orthopedic surgery, at the NASS meeting to be held from September 25 to 27 in Chicago. Implanet wilImplanet Announces the Appointment of Max W. Painter as Vice-President and General Manager of its US Subsidiary
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, announced the appointment of Max W. Painter as VP & General Manager of Implanet America. In this position, he will lead Implanet America, with the aim of optimizing its organizational structure to accelerateValidation by Sanyou Medical's Board of Directors of Its Commitment to Subscribe up to €5 ...
Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME plans) (Paris:ALIMP), a medical technology company specializingIMPLANET Signs an Agreement With Sanyou Medical for a Proposed Capital Increase With Preferential Subscription Rights
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, announced the conclusion of an agreement with Sanyou Medical, its reference shareholder, concerning its participation in an capital increase for a total of €5 million to strengthen Implanet's capital and enable the co
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Implanet
Sign Up For FreeTo access detailed company insights
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its activity revolves around two product ranges, a comprehensive innovative solution for improving the treatment of spinal pathologies (JAZZ® and OSD), as well as the MADISON implant for first-line prosthetic knee surgery. Impla... Read More
